You are currently viewing a new version of our website. To view the old version click .

Immune Response after Vaccination in Patients with Inflammatory Diseases

This special issue belongs to the section “Vaccines, Clinical Advancement, and Associated Immunology“.

Special Issue Information

Dear Colleagues,

Patients with autoimmune inflammatory diseases are among immune-incompetent patients. Altered functioning of the immune system and the use of immunomodulatory drugs make this group of patients more vulnerable to infections. The use of vaccines as a preventive measure against selected infectious diseases in patients with autoimmune inflammatory diseases is thus of paramount importance. Unfortunately, the same factors that make these patients more susceptible to infections also influence the post-vaccination response.

This Special Issue aims to feature papers that underscore aspects of the immune response after vaccination in patients with autoimmune inflammatory diseases, focusing on the immunogenicity of vaccines, the impact of immunomodulatory drugs on post-vaccination humoral and cellular responses, immunological mechanisms that influence the response in patients with autoimmune inflammatory diseases, and the translation of this knowledge into clinical practice. We welcome submissions of original research articles (both clinical and translational studies) as well as reviews.

We look forward to receiving your manuscripts.

Prof. Dr. Małgorzata Wisłowska
Guest Editor

Dr. Jakub Wroński
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • immunogenicity
  • cellular response
  • humoral response
  • vaccines
  • autoimmune diseases
  • inflammatory diseases
  • immunomodulatory treatment
  • disease-modifying antirheumatic drugs
  • biological drugs
  • targeted synthetic drugs

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X